Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 Å resolution
暂无分享,去创建一个
Petra Fromme | Giovanna Ghirlanda | P. Fromme | R. Fromme | G. Ghirlanda | Raimund Fromme | Zivile Katiliene | Zivile Katiliene
[1] Carole A Bewley,et al. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants. , 2002, Journal of molecular biology.
[2] C. Bewley,et al. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120. , 2001, Journal of the American Chemical Society.
[3] A. Gronenborn,et al. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. , 1999, Journal of molecular biology.
[4] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[5] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[6] G Marius Clore,et al. Using conjoined rigid body/torsion angle simulated annealing to determine the relative orientation of covalently linked protein domains from dipolar couplings. , 2002, Journal of magnetic resonance.
[7] A. Gronenborn,et al. Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization. , 2002, Chemistry & biology.
[8] V S Lamzin,et al. Modelling bound ligands in protein crystal structures. , 2004, Acta crystallographica. Section D, Biological crystallography.
[9] A. Wlodawer,et al. Proteins that bind high-mannose sugars of the HIV envelope. , 2005, Progress in biophysics and molecular biology.
[10] E. De Clercq. Emerging anti-HIV drugs , 2005, Expert opinion on emerging drugs.
[11] C J Margulis. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin. , 2005, The journal of physical chemistry. B.
[12] J. Balzarini. Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses? , 2007, Antiviral chemistry & chemotherapy.
[13] Alexander Wlodawer,et al. Structures of the Complexes of a Potent Anti-HIV Protein Cyanovirin-N and High Mannose Oligosaccharides* , 2002, The Journal of Biological Chemistry.
[14] Anastassis Perrakis,et al. Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.
[15] C. Bewley,et al. Engineering an obligate domain-swapped dimer of cyanovirin-N with enhanced anti-HIV activity. , 2002, Journal of the American Chemical Society.
[16] V S Lamzin,et al. ARP/wARP and molecular replacement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[17] A. Gronenborn,et al. The domain-swapped dimer of cyanovirin-N contains two sets of oligosaccharide binding sites in solution. , 2002, Biochemical and biophysical research communications.
[18] A. Gronenborn,et al. Solution structure of cyanovirin-N, a potent HIV-inactivating protein , 1998, Nature Structural Biology.
[19] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[20] Alexander Wlodawer,et al. Domain-Swapped Structure of the Potent Antiviral Protein Griffithsin and Its Mode of Carbohydrate Binding , 2006, Structure.
[21] D. Eisenberg,et al. Domain swapping: entangling alliances between proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] K. Gustafson,et al. Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin , 2003, Antimicrobial Agents and Chemotherapy.
[23] A. Gronenborn,et al. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition. , 2006, Protein engineering, design & selection : PEDS.
[24] C. Bewley,et al. Solution Structure of a Cyanovirin-N:Manα1-2Manα Complex , 2001 .
[25] Jean Dubuisson,et al. Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans* , 2006, Journal of Biological Chemistry.
[26] Talapady N. Bhat,et al. Calculation of an OMIT map , 1988 .
[27] Petra Fromme,et al. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity. , 2007, Biochemistry.
[28] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[29] Angela M Gronenborn,et al. Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity. , 2004, Structure.
[30] A. Gronenborn,et al. The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy. , 2005, Mini reviews in medicinal chemistry.
[31] L. Pannell,et al. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. , 2003, Biochemistry.
[32] C. Bewley. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. , 2001, Structure.
[33] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[34] L K Pannell,et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development , 1997, Antimicrobial agents and chemotherapy.
[35] A. Wlodawer,et al. Structural studies of algal lectins with anti-HIV activity. , 2006, Acta biochimica Polonica.
[36] G. Marius Clore,et al. Determination of the Relative Orientation of the Two Halves of the Domain-Swapped Dimer of Cyanovirin-N in Solution Using Dipolar Couplings and Rigid Body Minimization , 2000 .
[37] S J Wodak,et al. SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. , 1999, Acta crystallographica. Section D, Biological crystallography.
[38] Randy J Read,et al. Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Translation Functions Biological Crystallography Likelihood-enhanced Fast Translation Functions , 2022 .
[39] Alexander Wlodawer,et al. The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures. , 2002, Structure.
[40] R. Dwek,et al. Exploiting the defensive sugars of HIV-1 for drug and vaccine design , 2007, Nature.
[41] C. Bewley,et al. Crystal Structures of the HIV-1 Inhibitory Cyanobacterial Protein MVL Free and Bound to Man3GlcNAc2 , 2005, Journal of Biological Chemistry.
[42] David C. Richardson,et al. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes , 2004, Nucleic Acids Res..
[43] David Eisenberg,et al. 3D domain swapping: As domains continue to swap , 2002, Protein science : a publication of the Protein Society.
[44] Wladek Minor,et al. HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes. , 2006, Acta crystallographica. Section D, Biological crystallography.